IL20, interleukin 20, 50604

N. diseases: 111; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.020 Biomarker disease BEFREE In addition, anti-IL-20 mAb may attenuate the effect of IL-20 and suppress liver tumorigenesis <i>in vitro</i> and <i>in vivo</i>, indicating that anti-IL-20 mAbs may potentially serve as effective therapeutic agents for HCC. 30333881 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.020 AlteredExpression disease BEFREE IL-20 and cyclin D1 expression were also highly correlated in HCC patient specimens and 3 human HCC cell lines. 29242565 2017